Wordt geladen...
Advances in Prognostic Methylation Biomarkers for Prostate Cancer
There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2020-10-01
|
| Reeks: | Cancers |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/2072-6694/12/10/2993 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|